42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-721994
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 651f1205-1087-4304-b901-6566cac0e551
[Document ID] => 721994
[Document naam] => For meeting 19-10-2020clinicalstudy.docx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/document/VWS-WOO-08-721994
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-721994
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz
[DocumentPublicationDate] => 19 oktober 2020
[DocumentStatusCheckedDate] => 2026-04-28 05:37:32.390292
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 04:04:55
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 04:04:55
)
Document: VWS-WOO-08-721994
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201019
Geregistreerde documentnaam: For meeting 19-10-2020clinicalstudy.docx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie | 6.725 documenten waarvan 2.361 openbaar gemaakt Inventarislijst | 2026-03-11 05:06:49 |
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 05:06:49 |
| Request_Omvang publicatie_paginas | 6.725 | 2026-03-11 05:06:49 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/file/download/inventory | 2026-03-11 05:06:49 |
| About_Gelakte gegevens | 10.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 16:21:06 |
| document_SectionDownloadButton | 1 | 2025-09-01 16:21:06 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 16:21:06 |
| About_Datum document | 19 oktober 2020 | 2025-06-22 23:36:47 |
| About_Type bronbestand | Word-document, 2 pagina's | 2025-06-22 23:36:47 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:36:47 |
| About_Download als | PDF (656 KB) | 2025-06-22 23:36:47 |
| About_Documentnummer | 721994 | 2025-06-22 23:36:47 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkname_1 | 10.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:36:47 |
| document_SectionRequest | 1 | 2025-06-22 23:36:47 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode oktober 2020 | 2025-06-22 23:36:47 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz | 2025-06-22 23:36:47 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode oktober 2020 | 2025-06-22 23:36:47 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 19 april 2022 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en medicatie over de periode oktober 2020. | 2025-06-22 23:36:47 |
| Request_Periode | Oktober 2020 | 2025-06-22 23:36:47 |
| Request_Type besluit | Wob-besluit | 2025-06-22 23:36:47 |
| Request_Datum besluit | 19 april 2022 | 2025-06-22 23:36:47 |
| document_SectionHistory | 1 | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:36:47 |
| document_documentName | For meeting 19-10-2020clinicalstudy.docx | 2025-06-22 23:36:47 |
| document_documentType | Word-document | 2025-06-22 23:36:47 |
| document_documentPublicationDate | 2020-10-19 | 2025-06-22 23:36:47 |
| document_documentNumber | VWS-WOO-08-721994 | 2025-06-22 23:36:47 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:36:47 |
| document_SectionAbout | 1 | 2025-06-22 23:36:47 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over For meeting 19-10-2020clinicalstudy.docx (documentnummer 1ef8fbba-bc62-6cc0-b230-73caf8085b8d) | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking | 6.724 documenten, 7.928 pagina's Inventarislijst | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_documenten | 6.724 | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_paginas | 7.928 | 2025-06-22 23:36:47 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/file/download/inventory | 2025-06-22 23:36:47 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:36:47 |
| About_Gelakte gegevens | 10.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:36:47 |
| History Actie_1 | Bronbestand toegevoegd (pdf, 656 KB) | 2025-06-21 02:56:13 |
| History Datum_1 | 21 oktober 2024 17:10 | 2025-06-21 02:56:13 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-721994.pdf | 2025-04-19 13:22:32 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3350793-1027579-wjz/file/download/document/1ef8fbba-bc62-6cc0-b230-73caf8085b8d | 2025-04-19 13:22:32 |
| DocumentDownload_linkname | Download (pdf, 656 KB) | 2025-04-19 13:22:32 |
Archiefversies (8 rijen)
Archiefrij 1 — 2025-11-21 15:37:31
fromFile: VWS-WOO-3350793-1027579-wjz-1f0a50c5-6318-6ebe-9e4e-3b248d46981f.zip
fromFilePath: archieven_files\VWS-WOO-3350793-1027579-wjz-1f0a50c5-6318-6ebe-9e4e-3b248d46981f.zip
documentName: VWS-WOO-08-721994.pdf
documentType: pdf
documentCompressedSize: 375134
documentSize: 671747
documentCompressRatio: 55.844536708016555
documentDateModified: 2025-10-09 12:38:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:37:31
lastSeen: 2025-11-21 15:37:31
text: 721994
Trial design with 4 cohorts
Cohort A
Controls
r
N 260
Cohort B
Co
immunotherapy
Co
LU
LU
DO
N 112
4
Cohort C
Chemotherapy
N 260
Day
BL
DO
1
AE
Cohort D
7 10
grade 3 cohort A B C
DD
DD
28
60
■if
H
365
D
NSCLC chemo
immunotherapy
N 260
COVID 19 infection
outcome...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 868796038ad60abf4d92b453ece4a5c75b72acfcaf06db94c3c2ba5b3b1b14be
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 28f854ae-6eb5-4fa5-9eaa-4abd1c5f7f21
textDigestSHA256: 217496235a507db2808025088f66bc1e21e53abd29893b7dc3eb364a651be79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 2 — 2025-11-21 15:33:30
fromFile: VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.zip
documentName: VWS-WOO-08-721994.pdf
documentType: pdf
documentCompressedSize: 375134
documentSize: 671747
documentCompressRatio: 55.844536708016555
documentDateModified: 2025-10-09 12:38:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:33:30
lastSeen: 2025-11-21 15:33:30
text: 721994
Trial design with 4 cohorts
Cohort A
Controls
r
N 260
Cohort B
Co
immunotherapy
Co
LU
LU
DO
N 112
4
Cohort C
Chemotherapy
N 260
Day
BL
DO
1
AE
Cohort D
7 10
grade 3 cohort A B C
DD
DD
28
60
■if
H
365
D
NSCLC chemo
immunotherapy
N 260
COVID 19 infection
outcome...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 868796038ad60abf4d92b453ece4a5c75b72acfcaf06db94c3c2ba5b3b1b14be
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: bfe3b8fa-ec20-4664-ab51-2654efa85e02
textDigestSHA256: 217496235a507db2808025088f66bc1e21e53abd29893b7dc3eb364a651be79d
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 3 — 2025-09-07 17:30:13
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-721994.pdf
documentName: VWS-WOO-08-721994.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 671747
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:30:13
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:30:13
lastSeen: 2025-09-07 17:30:13
text: 721994
Trial design with 4cohorts
Cohort A
Controls
N260r
Cohort B
immunotherapy
N112Co
LUCo
LU
DO DO DD DD
■ifH 4 Cohort C
Chemotherapy
N260Day BL 1 28 60 710 365
AE grade 3cohort ABC D Cohort D
NSCLC chemo
immunotherapy
N260
COVID 19infection outcome influence onHRQoL cancer treatment outcome
Tria...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 868796038ad60abf4d92b453ece4a5c75b72acfcaf06db94c3c2ba5b3b1b14be
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_65724_3c666ede871ff7b6b6be07c48cf88479
textDigestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 4 — 2025-09-04 16:20:49
fromFile: VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.1.zip
documentName: VWS-WOO-08-721994.pdf
documentType: pdf
documentCompressedSize: 375134
documentSize: 671747
documentCompressRatio: 55.844536708016555
documentDateModified: 2025-05-01 20:59:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:20:49
lastSeen: 2025-11-21 13:47:41
text: 721994
Trial design with 4cohorts
Cohort A
Controls
N260r
Cohort B
immunotherapy
N112Co
LUCo
LU
DO DO DD DD
■ifH 4 Cohort C
Chemotherapy
N260Day BL 1 28 60 710 365
AE grade 3cohort ABC D Cohort D
NSCLC chemo
immunotherapy
N260
COVID 19infection outcome influence onHRQoL cancer treatment outcome
Tria...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 868796038ad60abf4d92b453ece4a5c75b72acfcaf06db94c3c2ba5b3b1b14be
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3350793-1027579-wjz-1f026c98-d906-6d24-b57a-65673e0af118.zip_1290
textDigestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 5 — 2025-05-22 12:03:42
fromFile: VWS-WOO-3350793-1027579-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3350793-1027579-wjz.zip
documentName: VWS-WOO-08-721994.pdf
documentType: pdf
documentCompressedSize: 375134
documentSize: 671747
documentCompressRatio: 55.844536708016555
documentDateModified: 2025-05-01 20:59:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-05-22 12:03:42
lastSeen: 2025-05-22 12:03:42
text: 721994
Trial design with 4cohorts
Cohort A
Controls
N260r
Cohort B
immunotherapy
N112Co
LUCo
LU
DO DO DD DD
■ifH 4 Cohort C
Chemotherapy
N260Day BL 1 28 60 710 365
AE grade 3cohort ABC D Cohort D
NSCLC chemo
immunotherapy
N260
COVID 19infection outcome influence onHRQoL cancer treatment outcome
Tria...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 424595
textDigestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 6 — 2025-02-27 09:25:02
fromFile: 2023.057-VWS-WOO-3350793-1027579-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3350793-1027579-wjz.zip
documentName: VWS-WOO-08-721994-For_meeting_19-10-2020clinicalstudy.docx.pdf
documentType: pdf
documentCompressedSize: 374372
documentSize: 671747
documentCompressRatio: 55.73110114373417
documentDateModified: 2024-12-05 09:40:50
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:02
lastSeen: 2025-02-27 09:25:02
text: 721994
Trial design with 4cohorts
Cohort A
Controls
N260r
Cohort B
immunotherapy
N112Co
LUCo
LU
DO DO DD DD
■ifH 4 Cohort C
Chemotherapy
N260Day BL 1 28 60 710 365
AE grade 3cohort ABC D Cohort D
NSCLC chemo
immunotherapy
N260
COVID 19infection outcome influence onHRQoL cancer treatment outcome
Tria...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 227769
textDigestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 7 — 2025-02-18 12:36:10
fromFile: Besluit__dossier_nr_-3c0952120a5d550692e659507432aada898836a9fff42682d8cc7d47fa30606c.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-3c0952120a5d550692e659507432aada898836a9fff42682d8cc7d47fa30606c.zip
documentName: VWS-WOO-08-721994-For_meeting_19-10-2020clinicalstudy.docx.pdf
documentType: pdf
documentCompressedSize: 374372
documentSize: 671747
documentCompressRatio: 55.73110114373417
documentDateModified: 2024-11-19 10:52:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:36:10
lastSeen: 2025-02-18 12:36:10
text: 721994
Trial design with 4cohorts
Cohort A
Controls
N260r
Cohort B
immunotherapy
N112Co
LUCo
LU
DO DO DD DD
■ifH 4 Cohort C
Chemotherapy
N260Day BL 1 28 60 710 365
AE grade 3cohort ABC D Cohort D
NSCLC chemo
immunotherapy
N260
COVID 19infection outcome influence onHRQoL cancer treatment outcome
Tria...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 186547
textDigestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
Archiefrij 8 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-3c0952120a5d550692e659507432aada898836a9fff42682d8cc7d47fa30606c.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-3c0952120a5d550692e659507432aada898836a9fff42682d8cc7d47fa30606c.zip
documentName: VWS-WOO-08-721994-2020-10-11_CSL-Seqirus_aCoV-2_Development_Update__-_Netherlands_.pdf
documentType: pdf
documentCompressedSize: 374372
documentSize: 671747
documentCompressRatio: 55.73110114373417
documentDateModified: 2024-10-21 17:17:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: 721994
Trial design with 4cohorts
Cohort A
Controls
N260r
Cohort B
immunotherapy
N112Co
LUCo
LU
DO DO DD DD
■ifH 4 Cohort C
Chemotherapy
N260Day BL 1 28 60 710 365
AE grade 3cohort ABC D Cohort D
NSCLC chemo
immunotherapy
N260
COVID 19infection outcome influence onHRQoL cancer treatment outcome
Tria...
noTextDate: 2025-09-06 02:21:53
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 868796038ad60abf4d92b453ece4a5c75b72acfcaf06db94c3c2ba5b3b1b14be
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 47850
textDigestSHA256: 38e39440a7bc963afe53835d4a2b9ba002229f31784d3d783ad9fa6a29655a20
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-721994
(dit is ook een speeltuin)